Subsequent studies have shown that in addition to leukemia cells, WT1 is overexpressed in a number of solid tumors, including tumors of the lung, breast, and colon, and can be used as a malignant tumor antigen for these tumors [12, 13]. This evidence concerns the gene WT1 and neoplasm.